Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10588571 | 0.88 | CYP1A2 (0.34) | ESR1CYP1A2SMN1; SMN2TSHR | |
| SCHEMBL6255892 | 0.78 | ALDH1A1 (0.39) | CYP1A2KMT2AMEN1KDM4ETSHR | |
| SCHEMBL39946 | 0.78 | ESR1 (0.44) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| Benzene SCHEMBL27985319 | 0.78 | ESR1 (0.44) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| SCHEMBL9818045 | 0.78 | ESR1 (0.44) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| SCHEMBL83762 | 0.76 | CHKA (0.46) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| Water SCHEMBL10786878 | 0.76 | ESR1 (0.43) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| Ammonia Solution, Strong SCHEMBL28398668 | 0.76 | ESR1 (0.43) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| SCHEMBL11032897 | 0.76 | CHKA (0.46) | ESR1CYP1A2S1PR1KMT2AMEN1 | |
| Methane SCHEMBL27634949 | 0.76 | ESR1 (0.43) | ESR1CYP1A2S1PR1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040658-A | Self-thickening polyacrylamide and preparation method and application thereof | 中海油田服务股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| EP-1414803-B1 | PYRAZOLYLCARBOXANILIDES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2012-12-12 | — | — | EP | claimed |
| US-7652022-B2 | N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; | NOVARTIS AG (CH) | 2010-01-26 | — | — | US | claimed |
| EP-1511730-B8 | DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES | NOVARTIS AG (CH) | 2009-04-08 | — | — | EP | claimed |
| US-20060128734-A1 | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | FLOERSHEIMER ANDREAS | 2006-06-15 | — | — | US | claimed |
| EP-1511730-A2 | DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES | Novartis AG (CH) | 2005-03-09 | — | — | EP | claimed |
| US-20040204470-A1 | Pyrazoylcarboxanilides as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-10-14 | — | — | US | claimed |
| WO-2003099771-A2 | DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES | NOVARTIS AG (CH) | 2003-12-04 | — | — | WO | claimed |
| US-20030225087-A1 | N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses | SAM-SUNG ELECTRONICS CO., LTD. (KR) | 2003-12-04 | — | — | US | claimed |
| WO-2003010153-A1 | N-ALKYL-N-PHENYLHYDROXYLAMINE COMPOUNDS CONTAINING METAL CHELATING GROUPS, THEIR PREPARATION AND THEIR THERAPEUTIC USES | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2003-02-06 | — | — | WO | claimed |
| US-4235730-A | DISPERSANTS | TEXACO INC. (US) | 1980-11-25 | — | — | US | claimed |
| JP-59010565-A | — | — | None | — | — | JP | disclosed |
| JP-52113930-A | — | — | None | — | — | JP | disclosed |
| JP-56106600-A | — | — | None | — | — | JP | disclosed |
| JP-61122265-A | — | — | None | — | — | JP | disclosed |
| US-4391805-A | FUNGICIDES, ANTIPROTOZOA AGENTS, BACTERICIDWS | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-07-05 | — | — | US | disclosed |
| EP-0050298-A2 | 1-(1,3-Dioxolan-2-ylmethyl) azoles, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-04-28 | — | — | EP | disclosed |
| JP-S56106600-A | NOVEL DETERMINING METHOD OF HYDROGEN PEROXIDE | WAKO PURE CHEM IND LTD | 1981-08-24 | — | — | JP | disclosed |
| JP-S52113930-A | PREPARATION OF ALKOXYANILINES | IHARA CHEM IND CO LTD | 1977-09-24 | — | — | JP | disclosed |
| US-4009201-A | PARTIALLY OR FULLY QUATERNIZED POLYAMINE ESTERS OF ACRYLIC ACIDS | ALCOLAC INC. (US) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204470-A1 | Pyrazoylcarboxanilides as fungicides | CYP1A1, CYP1B1, CYP2E1 | ESR1 3865/4885CYP1A2 6/4885S1PR1 2455/4885 |
| US-20030225087-A1 | N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses | SOD1, LPO, BAD | ESR1 2490/4885CYP1A2 2388/4885S1PR1 1644/4885 |
| US-20060128734-A1 | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | UCK2, PRKDC, PRKACA | ESR1 4387/4885CYP1A2 3905/4885S1PR1 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.